Executive Series: Anatara Lifesciences (ANR) Chairman & CEO, Dr Mel Bridges

CommSec

In this short video we discuss the current negotiations with #1 global animal health company, Zoetis, regarding a commercial agreement for the worldwide development, distribution and marketing of ANR’s Detach product, in addition to the submission of the Company’s dossier to the Australian Pesticides and Veterinary Medicines Authority (APVMA), seeking regulatory approval to register Detach for commercial marketing in Australia.


Comments

Please sign in to comment on this wire.